Mixed Dyslipidemias

Mixed Dyslipidemias is the indication for 10 drugs in DrugBank. It is covered by 21 curated, structured indications.

Also known as: Mixed Dyslipidemia
Classified under: Nutritional and Metabolic Diseases
Indicated drugs: Amlodipine
Atorvastatin
Fenofibrate
Fenofibric acid
Fluvastatin
Inclisiran
Lovastatin
Niacin
Pravastatin
Rosuvastatin

What you can answer from here — as of October 22, 2026

10Indicated drugsWith each drug's targets and mechanism

Listed above

21Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

54Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Mixed Dyslipidemias share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.